目前沒有任何討論
EKSO Ekso Bionics
-
-
(-)
單位：美金千元
| 科目 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | 2022/Q3 | 2022/Q2 | 2022/Q1 | 2021/Q4 | 2021/Q3 | 2021/Q2 | 2021/Q1 | 2020/Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
營業收入淨額
| 4,227 | 2,057 | 3,375 | 5,090 | 4,129 | 4,950 | 3,756 | 4,847 | 4,607 | 4,703 | 4,122 | 3,551 | 3,329 | 3,465 | 2,567 | 4,076 | 3,049 | 2,211 | 1,910 | 2,254 |
營業成本
| 1,678 | 1,238 | 1,569 | 2,376 | 1,920 | 2,313 | 1,805 | 2,478 | 2,151 | 2,449 | 2,122 | 1,873 | 1,643 | 1,824 | 1,358 | 1,661 | 1,242 | 919 | 675 | 893 |
營業毛利
| 2,549 | 819 | 1,806 | 2,714 | 2,209 | 2,637 | 1,951 | 2,369 | 2,456 | 2,254 | 2,000 | 1,678 | 1,686 | 1,641 | 1,209 | 2,415 | 1,807 | 1,292 | 1,235 | 1,361 |
營業費用
| 3,951 | 4,794 | - | - | - | - | - | - | 5,387 | 6,538 | 6,448 | 6,114 | 5,340 | - | 5,446 | 6,967 | 4,596 | 4,640 | 4,374 | 4,358 |
研發費用
| 550 | 851 | 988 | 845 | 777 | 1,116 | 1,136 | 1,313 | 1,160 | 1,398 | 1,154 | 946 | 1,062 | 998 | 999 | 818 | 618 | 709 | 603 | 712 |
推銷及管理費用
| 3,401 | 3,943 | 4,258 | 4,099 | 4,071 | 3,856 | 4,071 | 4,505 | 4,227 | 5,140 | 5,294 | 5,168 | 4,278 | 3,872 | 4,447 | 6,149 | 3,978 | 3,931 | 3,771 | 3,646 |
非經常性項目費用
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
其他營業費用
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
營業利益
| -1,402 | -3,975 | -3,440 | -2,230 | -2,639 | -2,335 | -3,256 | -3,449 | -2,931 | -4,284 | -4,448 | -4,436 | -3,654 | -3,229 | -4,237 | -4,552 | -2,789 | -3,348 | -3,139 | -2,997 |
其他收入及費用
| -1 | 1,330 | 621 | -1,124 | 646 | -7 | -116 | 301 | -370 | 114 | 186 | 1,324 | -616 | 280 | -356 | 1,725 | 855 | 2,102 | -505 | -624 |
利息費用
| 18 | 64 | 72 | 59 | 79 | 74 | 57 | 66 | 64 | 60 | 127 | 66 | 34 | 29 | 27 | 36 | 24 | 27 | 26 | 355 |
稅前純益
| -1,421 | -2,709 | -2,891 | -3,413 | -2,072 | -2,416 | -3,429 | -3,214 | -3,365 | -4,230 | -4,389 | -3,178 | -4,304 | -2,978 | -4,620 | -2,863 | -1,958 | -1,273 | -3,670 | -3,976 |
所得稅
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
稅後純益
| -1,421 | -2,709 | -2,891 | -3,413 | -2,072 | -2,416 | -3,429 | -3,214 | -3,365 | -4,230 | -4,389 | -3,178 | -4,304 | -2,978 | -4,620 | -2,863 | -1,958 | -1,273 | -3,670 | -3,976 |
基本每股稅後盈餘(元)
| -0.54 | -1.24 | -0.12 | -0.14 | -0.1 | -0.13 | -0.2 | - | -0.24 | -0.31 | -0.33 | -0.24 | -0.33 | -0.23 | -0.36 | -0.23 | -0.15 | -0.1 | -0.34 | - |
稀釋每股稅後盈餘(元)
| -0.34 | -1.21 | -0.12 | -0.14 | -0.1 | -0.13 | -0.2 | -0.22 | -0.24 | -0.31 | -0.33 | -0.24 | -0.33 | -0.23 | -0.36 | -0.26 | -0.18 | -0.1 | -0.34 | -0.03 |
基本平均股數(千股)
| 2,616 | 2,180 | 25,391 | 24,638 | 20,308 | 18,224 | 17,419 | - | 14,073 | 13,637 | 13,296 | 13,160 | 13,071 | 12,884 | 12,728 | 12,678 | 12,661 | 12,655 | 10,752 | - |
稀釋平均股數(千股)
| 2,616 | 2,180 | 25,391 | 24,638 | 20,308 | 18,224 | 17,419 | - | 14,073 | 13,637 | 13,296 | 13,160 | 13,071 | 12,884 | 12,728 | 12,678 | 12,710 | 12,737 | 10,752 | - |
還原基本每股稅後盈餘(元)
| -0.54 | -1.24 | -1.8 | -2.1 | -1.53 | -1.99 | -3 | - | -3.6 | -4.65 | -4.95 | -3.6 | -4.95 | -3.45 | -5.4 | -3.45 | -2.25 | -1.5 | -5.1 | - |
還原稀釋每股稅後盈餘(元)
| -0.34 | -1.21 | -1.8 | -2.03 | -1.45 | -1.92 | -3 | -3.3 | -3.6 | -4.65 | -4.95 | -3.6 | -4.95 | -3.45 | -5.4 | -3.9 | -2.7 | -1.5 | -5.1 | -6.45 |
還原基本平均股數(千股)
| 2,616 | 2,180 | 1,692 | 1,642 | 1,354 | 1,215 | 1,161 | - | 938 | 909 | 886 | 877 | 871 | 858 | 848 | 845 | 844 | 843 | 716 | - |
還原稀釋平均股數(千股)
| 2,616 | 2,180 | 1,692 | 1,642 | 1,354 | 1,215 | 1,161 | - | 938 | 909 | 886 | 877 | 871 | 858 | 848 | 845 | 847 | 849 | 716 | - |
EBITDA(千元)
| -1,036 | -2,268 | -2,441 | -2,956 | -1,586 | -1,945 | -2,966 | -2,716 | -2,877 | -3,742 | -3,848 | -2,857 | -4,102 | -2,718 | -4,462 | -3,048 | -2,005 | -1,097 | -3,517 | -3,438 |